Literature DB >> 1583132

Emergence of a new clone of serogroup C Neisseria meningitidis in São Paulo, Brazil.

C T Sacchi1, R C Zanella, D A Caugant, C E Frasch, N T Hidalgo, L G Milagres, L L Pessoa, S R Ramos, M C Camargo, C E Melles.   

Abstract

Serogroup C isolates of Neisseria meningitidis recovered from 121 patients with meningitis or septicemia in Greater São Paulo, Brazil, between 1976 and 1990 were analyzed with respect to serotype and multilocus enzyme genotype. The distribution of serotypes has changed since 1989 when serotype 2b started to replace serotype 2a. There were 48 distinct multilocus genotypes (electrophoretic types [ETs]) and 13 distinct complexes. Among the 41 serotype C:2b:- strains analyzed, 38 (93%) were found in complex 11. The percentage of complex 11 increased from 8% in 1988 to 50 and 66% in 1989 and 1990, respectively. Although we have been in an epidemic situation due to serogroup B:4:P1.15 ET-5 complex since 1988, the appearance and increase of a new unrelated strain, C:2b:- of ET-11 complex, in 1989 and 1990 provide enough data to conclude that the presence of two different complexes, ET-5 and -11, of N. meningitidis were responsible for the high levels of meningococcal disease in Greater São Paulo during this period.

Entities:  

Mesh:

Year:  1992        PMID: 1583132      PMCID: PMC265265          DOI: 10.1128/jcm.30.5.1282-1286.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics.

Authors:  R K Selander; D A Caugant; H Ochman; J M Musser; M N Gilmour; T S Whittam
Journal:  Appl Environ Microbiol       Date:  1986-05       Impact factor: 4.792

2.  [Bacteriological diagnosis of species of the genera Neisseria and Branhamella].

Authors:  J Y Riou; M Guibourdenche
Journal:  Ann Biol Clin (Paris)       Date:  1977       Impact factor: 0.459

3.  Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease.

Authors:  D A Caugant; L O Frøholm; K Bøvre; E Holten; C E Frasch; L F Mocca; W D Zollinger; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

4.  Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA.

Authors:  H Abdillahi; J T Poolman
Journal:  Microb Pathog       Date:  1988-01       Impact factor: 3.738

Review 5.  Clonal population structure of Neisseria meningitidis serogroup A isolated from epidemics and pandemics between 1915 and 1983.

Authors:  T Olyhoek; B A Crowe; M Achtman
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug

6.  A dot-immunobinding assay for monoclonal and other antibodies.

Authors:  R Hawkes; E Niday; J Gordon
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

7.  Epidemic disease due to serogroup C Neisseria meningitidis in Saõ Paulo, Brazil.

Authors:  J Souza de Morais; R S Munford; J B Risi; E Antezana; R A Feldman
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

8.  Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern.

Authors:  D A Caugant; L F Mocca; C E Frasch; L O Frøholm; W D Zollinger; R K Selander
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

9.  Epidemiologic studies of serotype antigens common to groups B and C Neisseria meningitidis.

Authors:  R S Munford; C M Patton; G W Gorman
Journal:  J Infect Dis       Date:  1975-03       Impact factor: 5.226

Review 10.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb
View more
  9 in total

1.  Meningococcal group C conjugate vaccines.

Authors:  J Maclennan
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

2.  Sequence diversity of Neisseria meningitidis 16S rRNA genes and use of 16S rRNA gene sequencing as a molecular subtyping tool.

Authors:  Claudio T Sacchi; Anne M Whitney; Michael W Reeves; Leonard W Mayer; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

3.  Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil.

Authors:  Soraia M Cordeiro; Alan B Neves; Cássio T Ribeiro; Maya L Petersen; Edilane L Gouveia; Guilherme S Ribeiro; Tatiana S Lôbo; Joice N Reis; Kátia M Salgado; Mitermayer G Reis; Albert I Ko
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-08-06       Impact factor: 2.184

4.  First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.

Authors:  R Almog; C Block; M Gdalevich; B Lev; M Wiener; S Ashkenazi
Journal:  Infection       Date:  1994 Mar-Apr       Impact factor: 3.553

5.  Clonal distribution of invasive Neisseria meningitidis serogroup C strains circulating from 1976 to 2005 in greater Sao Paulo, Brazil.

Authors:  Ana Paula Silva de Lemos; Teresa Ykuko Yara; Maria Cecília Outeiro Gorla; Maria Vaneide de Paiva; Adriana Lambert de Souza; Maria Inês Cappelletti Gonçalves; Samanta Cristine Grassi de Almeida; Gloria Regina Feitas do Valle; Claudio Tavares Sacchi
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

Review 6.  Molecular population genetic analysis of emerged bacterial pathogens: selected insights.

Authors:  J M Musser
Journal:  Emerg Infect Dis       Date:  1996 Jan-Mar       Impact factor: 6.883

7.  Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil.

Authors:  Ana Paula S Lemos; Lee H Harrison; Melina Lenser; Claudio T Sacchi
Journal:  J Infect       Date:  2010-01-06       Impact factor: 6.072

8.  Characterization of epidemic Neisseria meningitidis serogroup C strains in several Brazilian states.

Authors:  C T Sacchi; M L Tondella; A P de Lemos; M C Gorla; D B Berto; N H Kumiochi; C E Melles
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine.

Authors:  R Menezes Martins; A R S Périssé; L A B Camacho; M L Leal; M L S Maia; A Homma; E Jessouroun
Journal:  Braz J Infect Dis       Date:  2021-11-16       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.